Comparison of Two Apheresis Systems of COBE and Optia for Autologous Peripheral Blood Stem Cell Collection

Peripheral blood stem cell (PBSC) transplantation following myeloablative therapy is a mainstay of treatment for various types of malignancies. This study aimed to evaluate the differences between the Optia MNC and COBE Spectra MNC systems (Terumo BCT, Japan) according to apheresis procedures and th...

Full description

Saved in:
Bibliographic Details
Published inAnnals of laboratory medicine Vol. 37; no. 4; pp. 327 - 330
Main Authors Lee, Se-Na, Sohn, Ji Yeon, Kong, Jung Hee, Eom, Hyeon Seok, Lee, Hyewon, Kong, Sun-Young
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Society for Laboratory Medicine 01.07.2017
대한진단검사의학회
Subjects
Online AccessGet full text
ISSN2234-3806
2234-3814
2234-3814
DOI10.3343/alm.2017.37.4.327

Cover

Abstract Peripheral blood stem cell (PBSC) transplantation following myeloablative therapy is a mainstay of treatment for various types of malignancies. This study aimed to evaluate the differences between the Optia MNC and COBE Spectra MNC systems (Terumo BCT, Japan) according to apheresis procedures and the parameters of apheresis, products, and collection. The clinical data of 74 patients who underwent autologous PBSC collection from July 2012 to July 2015 were reviewed retrospectively. The patients comprised 48 (65%) men and 26 (35%) women with a median age of 56 yr (range, 23-66 yr). Of 216 procedures, 111 (51%) and 105 (49%) were processed by using COBE and Optia MNC, respectively. PBSC collection rates, throughput, numbers of stem cells retrieved, collection efficacy, and platelet loss were compared. There were no significant differences in the median CD34+ cell counts of collected products (0.61×10⁸ vs 0.94×10⁸), CD34 collection efficiency (43.5% vs 42.1%), and loss of platelets (40.1% vs 44.7%). The Spectra Optia MNC apheresis system was comparable to the COBE Spectra system in collecting autologous CD34+ hematopoietic stem cells and retention of platelets.
AbstractList Peripheral blood stem cell (PBSC) transplantation following myeloablative therapy is a mainstay of treatment for various types of malignancies. This study aimed to evaluate the differences between the Optia MNC and COBE Spectra MNC systems (Terumo BCT, Japan) according to apheresis procedures and the parameters of apheresis, products, and collection. The clinical data of 74 patients who underwent autologous PBSC collection from July 2012 to July 2015 were reviewed retrospectively. The patients comprised 48 (65%) men and 26 (35%) women with a median age of 56 yr (range, 23-66 yr). Of 216 procedures, 111 (51%) and 105 (49%) were processed by using COBE and Optia MNC, respectively. PBSC collection rates, throughput, numbers of stem cells retrieved, collection efficacy, and platelet loss were compared. There were no significant differences in the median CD34+ cell counts of collected products (0.61×10⁸ vs 0.94×10⁸), CD34 collection efficiency (43.5% vs 42.1%), and loss of platelets (40.1% vs 44.7%). The Spectra Optia MNC apheresis system was comparable to the COBE Spectra system in collecting autologous CD34+ hematopoietic stem cells and retention of platelets.
Peripheral blood stem cell (PBSC) transplantation following myeloablative therapy is a mainstay of treatment for various types of malignancies. This study aimed to evaluate the differences between the Optia MNC and COBE Spectra MNC systems (Terumo BCT, Japan) according to apheresis procedures and the parameters of apheresis, products, and collection. The clinical data of 74 patients who underwent autologous PBSC collection from July 2012 to July 2015 were reviewed retrospectively. The patients comprised 48 (65%) men and 26 (35%) women with a median age of 56 yr (range, 23–66 yr). Of 216 procedures, 111 (51%) and 105 (49%) were processed by using COBE and Optia MNC, respectively. PBSC collection rates, throughput, numbers of stem cells retrieved, collection efficacy, and platelet loss were compared. There were no significant differences in the median CD34+ cell counts of collected products (0.61×108 vs 0.94×108), CD34 collection efficiency (43.5% vs 42.1%), and loss of platelets (40.1% vs 44.7%). The Spectra Optia MNC apheresis system was comparable to the COBE Spectra system in collecting autologous CD34+ hematopoietic stem cells and retention of platelets.
Peripheral blood stem cell (PBSC) transplantation following myeloablative therapy is a mainstay of treatment for various types of malignancies. This study aimed to evaluate the differences between the Optia MNC and COBE Spectra MNC systems (Terumo BCT, Japan) according to apheresis procedures and the parameters of apheresis, products, and collection. The clinical data of 74 patients who underwent autologous PBSC collection from July 2012 to July 2015 were reviewed retrospectively. The patients comprised 48 (65%) men and 26 (35%) women with a median age of 56 yr (range, 23-66 yr). Of 216 procedures, 111 (51%) and 105 (49%) were processed by using COBE and Optia MNC, respectively. PBSC collection rates, throughput, numbers of stem cells retrieved, collection efficacy, and platelet loss were compared. There were no significant differences in the median CD34+ cell counts of collected products (0.61×10⁸ vs 0.94×10⁸), CD34 collection efficiency (43.5% vs 42.1%), and loss of platelets (40.1% vs 44.7%). The Spectra Optia MNC apheresis system was comparable to the COBE Spectra system in collecting autologous CD34+ hematopoietic stem cells and retention of platelets.Peripheral blood stem cell (PBSC) transplantation following myeloablative therapy is a mainstay of treatment for various types of malignancies. This study aimed to evaluate the differences between the Optia MNC and COBE Spectra MNC systems (Terumo BCT, Japan) according to apheresis procedures and the parameters of apheresis, products, and collection. The clinical data of 74 patients who underwent autologous PBSC collection from July 2012 to July 2015 were reviewed retrospectively. The patients comprised 48 (65%) men and 26 (35%) women with a median age of 56 yr (range, 23-66 yr). Of 216 procedures, 111 (51%) and 105 (49%) were processed by using COBE and Optia MNC, respectively. PBSC collection rates, throughput, numbers of stem cells retrieved, collection efficacy, and platelet loss were compared. There were no significant differences in the median CD34+ cell counts of collected products (0.61×10⁸ vs 0.94×10⁸), CD34 collection efficiency (43.5% vs 42.1%), and loss of platelets (40.1% vs 44.7%). The Spectra Optia MNC apheresis system was comparable to the COBE Spectra system in collecting autologous CD34+ hematopoietic stem cells and retention of platelets.
Peripheral blood stem cell (PBSC) transplantation following myeloablative therapy is a mainstay of treatment for various types of malignancies. This study aimed to evaluate the differences between the Optia MNC and COBE Spectra MNC systems (Terumo BCT, Japan) according to apheresis procedures and the parameters of apheresis, products, and collection. The clinical data of 74 patients who underwent autologous PBSC collection from July 2012 to July 2015 were reviewed retrospectively. The patients comprised 48 (65%) men and 26 (35%) women with a median age of 56 yr (range, 23–66 yr). Of 216 procedures, 111 (51%) and 105 (49%) were processed by using COBE and Optia MNC, respectively. PBSC collection rates, throughput, numbers of stem cells retrieved, collection efficacy, and platelet loss were compared. There were no significant differences in the median CD34+ cell counts of collected products (0.61×108 vs 0.94×108), CD34 collection efficiency (43.5% vs 42.1%), and loss of platelets (40.1% vs 44.7%). The Spectra Optia MNC apheresis system was comparable to the COBE Spectra system in collecting autologous CD34+ hematopoietic stem cells and retention of platelets. KCI Citation Count: 8
Author Eom, Hyeon Seok
Kong, Jung Hee
Lee, Hyewon
Sohn, Ji Yeon
Kong, Sun-Young
Lee, Se-Na
AuthorAffiliation 2 Center for Hematologic Malignancy, National Cancer Center, Goyang, Korea
3 Translational Epidemiology Branch, Hospital and Research Institute, National Cancer Center, Goyang, Korea
4 Department of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea
1 Department of Laboratory Medicine, Center for Diagnostic Oncology, National Cancer Center, Goyang, Korea
AuthorAffiliation_xml – name: 2 Center for Hematologic Malignancy, National Cancer Center, Goyang, Korea
– name: 4 Department of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea
– name: 3 Translational Epidemiology Branch, Hospital and Research Institute, National Cancer Center, Goyang, Korea
– name: 1 Department of Laboratory Medicine, Center for Diagnostic Oncology, National Cancer Center, Goyang, Korea
Author_xml – sequence: 1
  givenname: Se-Na
  surname: Lee
  fullname: Lee, Se-Na
  organization: Department of Laboratory Medicine, Center for Diagnostic Oncology, Goyang, Korea
– sequence: 2
  givenname: Ji Yeon
  surname: Sohn
  fullname: Sohn, Ji Yeon
  organization: Department of Laboratory Medicine, Center for Diagnostic Oncology, Goyang, Korea
– sequence: 3
  givenname: Jung Hee
  surname: Kong
  fullname: Kong, Jung Hee
  organization: Department of Laboratory Medicine, Center for Diagnostic Oncology, Goyang, Korea
– sequence: 4
  givenname: Hyeon Seok
  surname: Eom
  fullname: Eom, Hyeon Seok
  organization: Center for Hematologic Malignancy, Goyang, Korea, Department of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea
– sequence: 5
  givenname: Hyewon
  surname: Lee
  fullname: Lee, Hyewon
  organization: Center for Hematologic Malignancy, Goyang, Korea
– sequence: 6
  givenname: Sun-Young
  surname: Kong
  fullname: Kong, Sun-Young
  organization: Department of Laboratory Medicine, Center for Diagnostic Oncology, Goyang, Korea, Translational Epidemiology Branch, Hospital and Research Institute, Goyang, Korea, Department of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28445013$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002245816$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNqFUctu1DAUtVBRW0o_gA3yki4m-HHz2iBNowKVKk1Fp2vL4zitW8cOdkI1f4_DlBGwoJala-meh87xG3TgvNMIvaMk4xz4R2n7jBFaZrzMIOOsfIWOGeOw4BWFg_2bFEfoNMYHkk5BKKvJITpiFUBOKD9GD43vBxlM9A77Dq-fPF4O9zroaCK-2cZR93FeNKvzCyxdi1fDaCTufMDLafTW3_kp4msdzMySFp9b71t8k3i40dbixlur1Wi8e4ted9JGffo8T9Dt54t183Vxtfpy2SyvFgo4HxcqrwkraqkkKE0ryFW3AZAKoCyhailvtWprQtKtSM4Uga5jFc-rTbHheUH5CTrb6brQiUdlhJfm17zz4jGI5bf1paBAyoJBwrIddnKD3D5Ja8UQTC_DVlAi5p5F6lnMPQteChCp50T6tCMN06bXrdJuTMn3xNnu740z98n8h8iBzNmSwIdngeC_TzqOojdRpbak06lOQauaJe-65An6_k-vvcnvH0yAcgdQwccYdCeUGeXcd7I29r8x6D_Ml6P_BKBNwQM
CitedBy_id crossref_primary_10_1002_jca_21940
crossref_primary_10_1111_vox_13558
crossref_primary_10_1002_jca_21644
crossref_primary_10_1111_vox_13410
crossref_primary_10_3390_cancers14246259
crossref_primary_10_3390_ijms232012669
crossref_primary_10_1016_j_transci_2018_09_009
crossref_primary_10_1016_j_htct_2023_02_004
crossref_primary_10_1002_jca_21672
crossref_primary_10_1016_j_htct_2019_04_004
crossref_primary_10_1111_trf_16856
crossref_primary_10_17925_EOH_2019_15_1_22
crossref_primary_10_23736_S1825_859X_21_00119_5
crossref_primary_10_1111_trf_15096
crossref_primary_10_3925_jjtc_68_557
crossref_primary_10_1111_trf_15178
crossref_primary_10_1007_s40778_018_0115_y
crossref_primary_10_1016_j_transci_2017_11_007
crossref_primary_10_1111_vco_12446
crossref_primary_10_1002_jca_21959
crossref_primary_10_1016_j_clml_2017_12_010
crossref_primary_10_1002_jca_21917
crossref_primary_10_1111_ejh_14071
Cites_doi 10.1002/jca.10011
10.1016/j.transci.2013.06.002
10.1016/j.ejca.2006.07.008
10.1002/(SICI)1097-0320(19980415)34:2<61::AID-CYTO1>3.0.CO;2-F
10.1002/jca.21319
10.1111/j.1537-2995.2011.03414.x
10.1111/j.1423-0410.2011.01484.x
10.1080/14653240902923161
10.1046/j.1537-2995.2003.00422.x
10.1111/j.1537-2995.2007.01407.x
10.1111/trf.12448
10.1182/blood-2003-04-1045
10.1046/j.1537-2995.2001.41081008.x
10.1111/j.1537-2995.2010.02992.x
10.1002/jca.20148
10.1111/j.0041-1132.2004.04166.x
10.1002/jca.21341
ContentType Journal Article
Copyright The Korean Society for Laboratory Medicine.
The Korean Society for Laboratory Medicine 2017
Copyright_xml – notice: The Korean Society for Laboratory Medicine.
– notice: The Korean Society for Laboratory Medicine 2017
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ADTOC
UNPAY
ACYCR
DOI 10.3343/alm.2017.37.4.327
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2234-3814
EndPage 330
ExternalDocumentID oai_kci_go_kr_ARTI_1407624
10.3343/alm.2017.37.4.327
PMC5409026
28445013
10_3343_alm_2017_37_4_327
Genre Journal Article
Comparative Study
GrantInformation_xml – fundername: ;
  grantid: NCC-1210101
– fundername: ;
  grantid: 2014R1A2A2A01002553
GroupedDBID ---
5-W
53G
8JR
8XY
9ZL
AAYXX
ACYCR
ADBBV
ADRAZ
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
C~G
DIK
DYU
ECGQY
EF.
EMOBN
GX1
HYE
KQ8
M48
PGMZT
RPM
CGR
CUY
CVF
ECM
EIF
M~E
NPM
OK1
7X8
5PM
ADTOC
UNPAY
OZF
ID FETCH-LOGICAL-c433t-c590269aca4ce1845cfb44ac447748d13decd9009008052c04ff28358b6b35613
IEDL.DBID M48
ISSN 2234-3806
2234-3814
IngestDate Tue Nov 21 21:02:26 EST 2023
Sun Oct 26 01:40:44 EDT 2025
Tue Sep 30 16:31:43 EDT 2025
Fri Jul 11 12:35:55 EDT 2025
Thu Jan 02 23:09:44 EST 2025
Tue Jul 01 03:11:33 EDT 2025
Thu Apr 24 23:00:54 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Autologous
Collection
Apheresis
Efficiency
Stem cell
Language English
License The Korean Society for Laboratory Medicine.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
cc-by-nc
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c433t-c590269aca4ce1845cfb44ac447748d13decd9009008052c04ff28358b6b35613
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3343/alm.2017.37.4.327
PMID 28445013
PQID 1892334973
PQPubID 23479
PageCount 4
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_1407624
unpaywall_primary_10_3343_alm_2017_37_4_327
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5409026
proquest_miscellaneous_1892334973
pubmed_primary_28445013
crossref_citationtrail_10_3343_alm_2017_37_4_327
crossref_primary_10_3343_alm_2017_37_4_327
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-07-01
PublicationDateYYYYMMDD 2017-07-01
PublicationDate_xml – month: 07
  year: 2017
  text: 2017-07-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Annals of laboratory medicine
PublicationTitleAlternate Ann Lab Med
PublicationYear 2017
Publisher The Korean Society for Laboratory Medicine
대한진단검사의학회
Publisher_xml – name: The Korean Society for Laboratory Medicine
– name: 대한진단검사의학회
References Long (10.3343/alm.2017.37.4.327_ref17) 2015; 30
Keeney (10.3343/alm.2017.37.4.327_ref13) 1998; 34
Sutherland (10.3343/alm.2017.37.4.327_ref14) 2009; 11
Heuft (10.3343/alm.2017.37.4.327_ref4) 2001; 41
Lefrère (10.3343/alm.2017.37.4.327_ref12) 2007; 47
Brauninger (10.3343/alm.2017.37.4.327_ref8) 2011; 101
Kim (10.3343/alm.2017.37.4.327_ref11) 2007; 22
Ikeda (10.3343/alm.2017.37.4.327_ref3) 2003; 43
Suh (10.3343/alm.2017.37.4.327_ref10) 2004; 44
Reinhardt (10.3343/alm.2017.37.4.327_ref16) 2011; 51
Barlogie (10.3343/alm.2017.37.4.327_ref1) 2004; 103
Cherqaoui (10.3343/alm.2017.37.4.327_ref20) 2014; 54
Ford (10.3343/alm.2017.37.4.327_ref15) 2002; 17
Lee (10.3343/alm.2017.37.4.327_ref19) 2006; 17
Karafin (10.3343/alm.2017.37.4.327_ref5) 2014; 29
Li (10.3343/alm.2017.37.4.327_ref2) 2006; 42
10.3343/alm.2017.37.4.327_ref9
Brauninger (10.3343/alm.2017.37.4.327_ref6) 2012; 52
10.3343/alm.2017.37.4.327_ref7
Flommersfeld (10.3343/alm.2017.37.4.327_ref18) 2013; 49
9579602 - Cytometry. 1998 Apr 15;34(2):61-70
11948701 - J Clin Apher. 2002;17(1):17-20
12757534 - Transfusion. 2003 Jun;43(6):814-9
21517897 - Vox Sang. 2011 Oct;101(3):237-46
24117598 - Transfusion. 2014 May;54(5):1371-8
12969978 - Blood. 2004 Jan 1;103(1):20-32
15584992 - Transfusion. 2004 Dec;44(12):1762-8
24941931 - J Clin Apher. 2015 Feb;30(1):1-7
16979889 - Eur J Cancer. 2006 Dec;42(18):3274-86
11493732 - Transfusion. 2001 Aug;41(8):1008-13
19513900 - Cytotherapy. 2009;11(5):595-605
21155834 - Transfusion. 2011 Jun;51(6):1321-30
17880017 - J Clin Apher. 2007;22(5):277-82
23827328 - Transfus Apher Sci. 2013 Dec;49(3):428-33
22044384 - Transfusion. 2012 May;52(5):1137-45
17880611 - Transfusion. 2007 Oct;47(10):1851-7
24677347 - J Clin Apher. 2014 Oct;29(5):273-80
References_xml – volume: 17
  start-page: 17
  year: 2002
  ident: 10.3343/alm.2017.37.4.327_ref15
  publication-title: J Clin Apher
  doi: 10.1002/jca.10011
– volume: 49
  start-page: 428
  year: 2013
  ident: 10.3343/alm.2017.37.4.327_ref18
  publication-title: Transfus Apher Sci
  doi: 10.1016/j.transci.2013.06.002
– volume: 42
  start-page: 3274
  year: 2006
  ident: 10.3343/alm.2017.37.4.327_ref2
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2006.07.008
– volume: 34
  start-page: 61
  year: 1998
  ident: 10.3343/alm.2017.37.4.327_ref13
  publication-title: Cytometry
  doi: 10.1002/(SICI)1097-0320(19980415)34:2<61::AID-CYTO1>3.0.CO;2-F
– volume: 29
  start-page: 273
  year: 2014
  ident: 10.3343/alm.2017.37.4.327_ref5
  publication-title: J Clin Apher
  doi: 10.1002/jca.21319
– volume: 52
  start-page: 1137
  year: 2012
  ident: 10.3343/alm.2017.37.4.327_ref6
  publication-title: Transfusion
  doi: 10.1111/j.1537-2995.2011.03414.x
– volume: 101
  start-page: 237
  year: 2011
  ident: 10.3343/alm.2017.37.4.327_ref8
  publication-title: Vox Sang
  doi: 10.1111/j.1423-0410.2011.01484.x
– volume: 11
  start-page: 595
  year: 2009
  ident: 10.3343/alm.2017.37.4.327_ref14
  publication-title: Cytotherapy
  doi: 10.1080/14653240902923161
– volume: 43
  start-page: 814
  year: 2003
  ident: 10.3343/alm.2017.37.4.327_ref3
  publication-title: Transfusion
  doi: 10.1046/j.1537-2995.2003.00422.x
– volume: 47
  start-page: 1851
  year: 2007
  ident: 10.3343/alm.2017.37.4.327_ref12
  publication-title: Transfusion
  doi: 10.1111/j.1537-2995.2007.01407.x
– volume: 54
  start-page: 1371
  year: 2014
  ident: 10.3343/alm.2017.37.4.327_ref20
  publication-title: Transfusion
  doi: 10.1111/trf.12448
– volume: 17
  start-page: 39
  year: 2006
  ident: 10.3343/alm.2017.37.4.327_ref19
  publication-title: Korean J Blood Transfus
– ident: 10.3343/alm.2017.37.4.327_ref7
– volume: 103
  start-page: 20
  year: 2004
  ident: 10.3343/alm.2017.37.4.327_ref1
  publication-title: Blood
  doi: 10.1182/blood-2003-04-1045
– ident: 10.3343/alm.2017.37.4.327_ref9
– volume: 41
  start-page: 1008
  year: 2001
  ident: 10.3343/alm.2017.37.4.327_ref4
  publication-title: Transfusion
  doi: 10.1046/j.1537-2995.2001.41081008.x
– volume: 51
  start-page: 1321
  year: 2011
  ident: 10.3343/alm.2017.37.4.327_ref16
  publication-title: Transfusion
  doi: 10.1111/j.1537-2995.2010.02992.x
– volume: 22
  start-page: 277
  year: 2007
  ident: 10.3343/alm.2017.37.4.327_ref11
  publication-title: J Clin Apher
  doi: 10.1002/jca.20148
– volume: 44
  start-page: 1762
  year: 2004
  ident: 10.3343/alm.2017.37.4.327_ref10
  publication-title: Transfusion
  doi: 10.1111/j.0041-1132.2004.04166.x
– volume: 30
  start-page: 1
  year: 2015
  ident: 10.3343/alm.2017.37.4.327_ref17
  publication-title: J Clin Apher
  doi: 10.1002/jca.21341
– reference: 24677347 - J Clin Apher. 2014 Oct;29(5):273-80
– reference: 21155834 - Transfusion. 2011 Jun;51(6):1321-30
– reference: 21517897 - Vox Sang. 2011 Oct;101(3):237-46
– reference: 23827328 - Transfus Apher Sci. 2013 Dec;49(3):428-33
– reference: 17880017 - J Clin Apher. 2007;22(5):277-82
– reference: 11948701 - J Clin Apher. 2002;17(1):17-20
– reference: 16979889 - Eur J Cancer. 2006 Dec;42(18):3274-86
– reference: 9579602 - Cytometry. 1998 Apr 15;34(2):61-70
– reference: 17880611 - Transfusion. 2007 Oct;47(10):1851-7
– reference: 24941931 - J Clin Apher. 2015 Feb;30(1):1-7
– reference: 12969978 - Blood. 2004 Jan 1;103(1):20-32
– reference: 12757534 - Transfusion. 2003 Jun;43(6):814-9
– reference: 11493732 - Transfusion. 2001 Aug;41(8):1008-13
– reference: 24117598 - Transfusion. 2014 May;54(5):1371-8
– reference: 15584992 - Transfusion. 2004 Dec;44(12):1762-8
– reference: 19513900 - Cytotherapy. 2009;11(5):595-605
– reference: 22044384 - Transfusion. 2012 May;52(5):1137-45
SSID ssj0000601290
Score 2.2221177
Snippet Peripheral blood stem cell (PBSC) transplantation following myeloablative therapy is a mainstay of treatment for various types of malignancies. This study...
SourceID nrf
unpaywall
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 327
SubjectTerms Adult
Antigens, CD34
Blood Cell Count
Blood Component Removal - methods
Brief Communication
Female
Humans
Male
Middle Aged
Peripheral Blood Stem Cell Transplantation
Peripheral Blood Stem Cells - cytology
Peripheral Blood Stem Cells - metabolism
Transplantation, Autologous
Young Adult
병리학
SummonAdditionalLinks – databaseName: Unpaywall
  dbid: UNPAY
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELboVgIulDehBRnECZQ0icd5HLerVgWpD4muVE6W4ziwbJRUuxtV8OuZSdKoWyoepySyHcvjcfxNZvwNY-_CVOui0Ki8Jo1csH7hJjnkrkyiAOF2JpOWMv_oODqcwqdzed6TRdNZmGv-eyFA7OqSjosHsSdiDzwRxhtsM5IIu0dsc3p8Ov5CyeNCAa5I2jya_X0AnQfz9nes7UEb1aK4DV7-HiV5r6ku9I9LXZbXtqCDrS54a9kyF1LkydxrVplnft7gdfyn0T1kD3ogysed5jxid2z1mN096l3tT9j3yZChkNcFP7us-ZgoCOxytuQ9zzkVTE729rmucn6CHx_NEQPzcdMmxa2bJT9FBW-JC0q-RyHy_DO24xNblrz9ZdGeqnjKpgf7Z5NDt0_M4BoQYuUa4nyJUm00GIsmojRFBqANAILJJA9Ebk2eInojPCpD40NREK9bkkWZIIvlGRtVdWVfMJ4HEKTW-KmJC4hzkwgrTZYJDTrMrZQO86-mSpmetZySZ5QKrReSoUIZKpKhErEChTJ02PuhyUVH2fGnym9x_tXczBQRbdP1a63mC4XmxEe0i3zcLMBhb67UQ-HqI5eKrixKUQUJAmQBaSwc9rxTl6FP3PhBIsJ2WLymSEMF6nC9pJp9axm-EUaThB32YVC5vw_l5X_V3mb36bmLPN5ho9Wisa8QX62y1_3K-gWvARwj
  priority: 102
  providerName: Unpaywall
Title Comparison of Two Apheresis Systems of COBE and Optia for Autologous Peripheral Blood Stem Cell Collection
URI https://www.ncbi.nlm.nih.gov/pubmed/28445013
https://www.proquest.com/docview/1892334973
https://pubmed.ncbi.nlm.nih.gov/PMC5409026
https://doi.org/10.3343/alm.2017.37.4.327
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002245816
UnpaywallVersion publishedVersion
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Annals of Laboratory Medicine, 2017, 37(4), , pp.327-330
journalDatabaseRights – providerCode: PRVCAB
  databaseName: Nutrition and Food Sciences Database
  customDbUrl:
  eissn: 2234-3814
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000601290
  issn: 2234-3806
  databaseCode: DYU
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://www.cabidigitallibrary.org/product/zd
  providerName: CAB International
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2234-3814
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000601290
  issn: 2234-3806
  databaseCode: KQ8
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 2234-3814
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000601290
  issn: 2234-3806
  databaseCode: DIK
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 2234-3814
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000601290
  issn: 2234-3806
  databaseCode: GX1
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVERR
  databaseName: KoreaMed Open Access
  customDbUrl:
  eissn: 2234-3814
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000601290
  issn: 2234-3806
  databaseCode: 5-W
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://koreamed.org/journals
  providerName: Korean Association of Medical Journal Editors
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2234-3814
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000601290
  issn: 2234-3806
  databaseCode: RPM
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVFZP
  databaseName: Scholars Portal - Open Access
  customDbUrl:
  eissn: 2234-3814
  dateEnd: 20250930
  omitProxy: true
  ssIdentifier: ssj0000601290
  issn: 2234-3806
  databaseCode: M48
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Zb9QwELZ6SNAXxN1wrAziCZQlicc5HhDarloVpG0r0Ujtk-U4DiyNkrKHSv89M0k2YsUCT3mwLSeeceb7fHzD2Jsg0booNDqvSUIXrFe4cQ65K-PQR7idybiRzJ-chMcpfL6QF1tsld6qG8D5RmpH-aTSWTn8-eP2I074D8Q4BYj3uqQr5X40FNEQhiKIttkuBqqEMjlMOrTf_pibVZd2b3NzS9IGjgGk54u1QLVdzYpNGPTPo5R3l9W1vr3RZflbnDq6z-51AJOPWo94wLZs9ZDdmXRb6I_Y93GfeZDXBT-_qfmIpAXsfDrnnX45FYxPDw65rnJ-ij8VzRHb8tGySXZbL-f8DB23ESQo-QEdfedfsB0f27LkzVJEc1viMUuPDs_Hx26XcME1IMTCNaTlEibaaDAWqZ80RQagDQCCxDj3RW5NniAqI5wpA-NBUZBeW5yFmSAm8oTtVHVl9xnPffATa7zERAVEuYmFlSbLhAYd5FZKh3mr0VWmUyOnpBilQlZCtlFoG0W2USJSoNA2DnvbN7lupTj-Vfk1mkxdmakiAW16fq3V1UwhTfiEfMfDIAAOe7WyqMJZRVslurI4isqPEfgKSCLhsKethfs-Vw7isGjN9n0F6nC9pJp-a5S7JXllEDrsXe8l__-UZ399g-dsj2q2p4dfsJ3FbGlfIkZaZANkB5fpoPH_AdtNT85Gl78AEogOzQ
linkProvider Scholars Portal
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELboVgIulDehBRnECZQ0icd5HLerVgWpD4muVE6W4ziwbJRUuxtV8OuZSdKoWyoepySyHcvjcfxNZvwNY-_CVOui0Ki8Jo1csH7hJjnkrkyiAOF2JpOWMv_oODqcwqdzed6TRdNZmGv-eyFA7OqSjosHsSdiDzwRxhtsM5IIu0dsc3p8Ov5CyeNCAa5I2jya_X0AnQfz9nes7UEb1aK4DV7-HiV5r6ku9I9LXZbXtqCDrS54a9kyF1LkydxrVplnft7gdfyn0T1kD3ogysed5jxid2z1mN096l3tT9j3yZChkNcFP7us-ZgoCOxytuQ9zzkVTE729rmucn6CHx_NEQPzcdMmxa2bJT9FBW-JC0q-RyHy_DO24xNblrz9ZdGeqnjKpgf7Z5NDt0_M4BoQYuUa4nyJUm00GIsmojRFBqANAILJJA9Ebk2eInojPCpD40NREK9bkkWZIIvlGRtVdWVfMJ4HEKTW-KmJC4hzkwgrTZYJDTrMrZQO86-mSpmetZySZ5QKrReSoUIZKpKhErEChTJ02PuhyUVH2fGnym9x_tXczBQRbdP1a63mC4XmxEe0i3zcLMBhb67UQ-HqI5eKrixKUQUJAmQBaSwc9rxTl6FP3PhBIsJ2WLymSEMF6nC9pJp9axm-EUaThB32YVC5vw_l5X_V3mb36bmLPN5ho9Wisa8QX62y1_3K-gWvARwj
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+Two+Apheresis+Systems+of+COBE+and+Optia+for+Autologous+Peripheral+Blood+Stem+Cell+Collection&rft.jtitle=Annals+of+laboratory+medicine&rft.au=Lee%2C+Se+Na&rft.au=Sohn%2C+Ji+Yeon&rft.au=Kong%2C+Jung+Hee&rft.au=Eom%2C+Hyeon+Seok&rft.date=2017-07-01&rft.eissn=2234-3814&rft.volume=37&rft.issue=4&rft.spage=327&rft_id=info:doi/10.3343%2Falm.2017.37.4.327&rft_id=info%3Apmid%2F28445013&rft.externalDocID=28445013
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-3806&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-3806&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-3806&client=summon